1	Ceftriaxona	ceftriaxona	NC00SC0	C0007561	sustancia	0-11	497(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
2	2	2	Z	-	-	12-13	497(1)_ANS_clinical_caseMIR	SENT1	-	-
3	g	g	NCMN000	-	-	14-15	497(1)_ANS_clinical_caseMIR	SENT1	-	-
4	,	,	Fc	-	-	15-16	497(1)_ANS_clinical_caseMIR	SENT1	-	-
5	azitromicina	azitromicina	NC00SC0	C0052796	producto#sustancia	17-29	497(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
6	500	500	Z	-	-	30-33	497(1)_ANS_clinical_caseMIR	SENT1	-	-
7	mg	mg	NCMN000	-	-	34-36	497(1)_ANS_clinical_caseMIR	SENT1	-	-
8	cada	cada	NC00SC0	C0456696#C1275548_1	calificador_1	37-41	497(1)_ANS_clinical_caseMIR	SENT1	-	-
9	24	24	Z	C0456696#C1275548_2	calificador_2	42-44	497(1)_ANS_clinical_caseMIR	SENT1	-	-
10	horas	hora	NCFP000	C0456696#C1275548_3	calificador_3	45-50	497(1)_ANS_clinical_caseMIR	SENT1	-	-
11	y	y	CC	C1706368	calificador	51-52	497(1)_ANS_clinical_caseMIR	SENT1	-	-
12	trimetoprim-sulfametoxazol	trimetoprim-sulfametoxazol	NCMS000	-	-	53-79	497(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
13	5	5		-	-	80-81	497(1)_ANS_clinical_caseMIR	SENT1	-	-
14	mg/kg/8	mg/kg/8	Z	-	-	82-89	497(1)_ANS_clinical_caseMIR	SENT1	-	-
15	h	h	NCMN000	C0439227	calificador	90-91	497(1)_ANS_clinical_caseMIR	SENT1	-	-
16	(	(	Fpa	-	-	92-93	497(1)_ANS_clinical_caseMIR	SENT1	-	-
17	basado	basar	VMP00SM	-	-	93-99	497(1)_ANS_clinical_caseMIR	SENT1	-	-
18	en	en	SPS00	C1720294#C0332285	calificador#atributo	100-102	497(1)_ANS_clinical_caseMIR	SENT1	-	-
19	dosis	dosis	NCFN000	-	-	103-108	497(1)_ANS_clinical_caseMIR	SENT1	-	-
20	de	de	SPS00	C0332285	atributo	109-111	497(1)_ANS_clinical_caseMIR	SENT1	-	-
21	trimetoprim	trimetoprim	NC00BO0	-	-	112-123	497(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
22	)	)	Fpt	-	-	123-124	497(1)_ANS_clinical_caseMIR	SENT1	-	-
23	.	.	Fp	-	-	124-125	497(1)_ANS_clinical_caseMIR	SENT1	-	-

